09-10-2026 23:32 via medpagetoday.com

Decades-Old Schizophrenia Drug Wins Approval for New Formulation

(MedPage Today) -- The FDA approved an easier-to-use once-monthly subcutaneous injectable form of olanzapine (Weltruza) for schizophrenia in adults, Teva Pharmaceuticals announced on Friday.
A decades-old drug, olanzapine in its oral form is the...
Read more »

Medical Industry news



Best Strategy for Early Septic Shock; Hormone Therapy and Blood Clot Risk
Everything You Should Know About Emergency Doctors But Were Too Afraid to Ask
Cost of Drugs From Canada Set to Soar for Millions of Americans Due to Federal Rule
New Oral Drug Approved for Herpes Lesions
Are ADHD and Dementia Linked?
Biden Cancer Update; 'Big Bet' on Vaccines; Tucatinib Breast Cancer Approval Expands
Popular Longevity Supplement Fails to Meet Endpoint in Parkinson's Trial
Treatment Landscape for Dermatomyositis Is Evolving
Therapeutic Evolution in Gastroesophageal Adenocarcinoma
Christa Pike's Survival Wasn't a Miracle. That's What Should Scare Us.
Moscow's Secrecy About Suspected Plague Case Follows a Pattern From the Soviet Era
Is It Viral Gastroenteritis? Maybe Check the Latest Weather Patterns
HHS Touts New Vaccine-Injury Initiatives
FDA Approves Adjuvant Atezolizumab for Certain Colon Cancers
Desktop versie